MedTrace Logo

Mitochondrial Dysfunction and Insulin Resistance in Skeletal Muscle

NCT04558190 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2021-12-02

No results posted yet for this study

Summary

The purpose of the study is to evaluate the link between insulin resistance and alterations in skeletal muscle mitochondrial redox homeostasis

Conditions

Interventions

DRUG

Intralipid, 20% Intravenous Emulsion

Lipid infusion

DIETARY_SUPPLEMENT

MitoQ

Oral administration of MitoQ capsules

DRUG

Salbutamol

Beta2-agonist infusion

Sponsors & Collaborators

  • University of Copenhagen

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
40 Years
Max Age
60 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-09-02
Primary Completion
2021-11-01
Completion
2021-11-01

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04558190 on ClinicalTrials.gov